Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Mabs|September 6, 2018
Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemiaDouglas D Leipold, Isabel Figueroa, Shabkhaiz Masih, et al.
Journal of Translational Medicine|April 19, 2015
Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methodsJintang He, Athena A Schepmoes, Tujin Shi, et al.
Molecular Oncology|October 1, 2014
Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancerJintang He, Xuefei Sun, Tujin Shi, et al.
Bioconjugate Chemistry|February 27, 2018
Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker ModificationDian Su, Katherine R Kozak, Jack Sadowsky, et al.
Bioconjugate Chemistry|June 22, 2017
Development of Efficient Chemistry to Generate Site-Specific Disulfide-Linked Protein- and Peptide-Payload Conjugates: Application to THIOMAB Antibody-Drug ConjugatesJack D Sadowsky, Thomas H Pillow, Jinhua Chen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 2, 2018
Conjugation of Indoles to Antibodies through a Novel Self-Immolating LinkerPeter S Dragovich, Robert A Blake, Chunjiao Chen, et al.
Molecular Cancer Therapeutics|February 23, 2017
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide LinkersThomas H Pillow, Melissa Schutten, Shang-Fan Yu, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2020
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)Peter S Dragovich, Pragya Adhikari, Robert A Blake, et al.
Chemical Science|April 13, 2022
A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptidesNeelie Zacharias, Vladimir N Podust, Kimberly K Kajihara, et al.
Bioconjugate Chemistry|April 11, 2019
Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In VivoDian Su, Jinhua Chen, Ely Cosino, et al.
Pageof 5